876
33419922701003469111
|350227010019
VNITŘNÍ4268043010746106127172220280301
LÉKAŘSTVÍ748804301074185130188236280325378400
/11948043010731
Vnitř1270804301074693112140166
Lék.1456804301074083122140
2023;69(5):329-3341615804301074487129173186232274298341363378422463506536577618663
/23238043010731
www.casopisvnitrnilekarstvi.cz442680430107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
CO42522701003989
JE52922701001961
NOVÉHO605227010053104150192244295
V…91522701004694
Co42533701003976
je51833701001449
nového58333701003776112146184223
v822337010035
pneumologii87333701003875111149208247263302341356371
–1260337010038
rok13143370100246297
2022142733701003375109144
https://www.wabipacademy.com/publications/abstracts/wcbip2022/131-wcbip‑congress2022-published‑abstracts/file.425554083375781119145157182202252304355366414445483498536568599631669702759788798829864921946983102010581073108711181150117011851222125912841309133913771402142514451477150815311558158316321663170117161754178618191850188419101942197120002018206920992137215221902212224522802318235523762409243524604256540833468101136156196234274289304331368403443465497537563587608641673697725751768785801835848
3.4257530853549
Pallenberg48375408335647891124160197230250286
ST,778754083326572
Pust859754083357094115
MM,98475408354106118
Rosenboom1112754083357195128164201238274330
I,14527540831425
et14877540833354
al.1550754083324556
Impact16167540831470107138168190
of18157540833755
Elexacaftor/Tezacaftor/Ivacaftor1879754083324578108138168199216239274294315349378406437467498515538573592614628658689719750767790825844
Therapy273375408332691021211524258540833867
on5028540833672
the584854083215790
Cystic683854083396590111124154
Fibrosis846854083324582102137161174198
Airway1053854083415473124155183
Microbial1245854083546897117151189202232246
Metagenome.15008540835486107137174207242278334367377
Microbiol1886854083546797116151189202238252
Spectr.21478540833269102132155174182
2022;2339854083336596128139
10(5):e01454-22.2487854083346381112128138170204233262293326347375408419
4.4259530853651
Doligalski4959540834584100115154186201227257274
CT,787954083407584
McKinzie8899540835587122139177206222256
CJ,1164954083406678
Yang12609540833665103142
A,14209540834155
et14949540833456
al.1568954083324760
Poor16469540833672111133
tolerability1797954083215874109130163202218233248271304
of21209540833756
cystic2194954083326592115131162
fibrosis237595408317347394131158173199
transmembrane25929540832243761141411982332914251054083396093131166
conductance60910540833168106145183215239272310342376
regulator10021054083215595132148180201238260
modulator127910540835896136173189221243280301
therapy15981054083215994116149188219
in183410540831553
lung19041054083155391130
transplant20511054083224376114141180196228266287
recipients.23561054083205487102141157192230251279293
Pharmacother2666105408335731051261842174251154083316890128163184
J625115408324
Hum66411540834482140
Pharmacol81911540833573105126185217249286302
Drug113611540834667106145
Ther.129611540833372107128138
2022;42(7):580-584.145011540833468101136148183215233267287299334368403427461495532544
5.42512530853650
Spoletini48912540833271110126161183198236251
G,75412540834457
Gillgrass825125408343597489128149182209235
L,107412540833145
Pollard11321254083357288103135157195
K,134012540833550
et140312540833456
al.14731254083324760
Dose154712540834584110145
adjustments17061254083327186123150173231266304326353
of207312540833756
Elexacaftor/Tezacaftor/Ivacaftor214312540833348831141471792122312562933143373744054344685005335525776146356586747077404251354083316483108145167
in61013540831553
response6811354083215582121159198224259
to95913540832158
mental103613540835792130152185200
health125413540833873105120143181
side14531354083264180115
effects15861354083345473107140164192
in179613540831553
adults186713540833271109124146174
with20601354083506688126
cystic22051354083316491115130162
fibrosis.2385135408317347395132159174200213
J2617135408324
Cyst26591354083406895118
Fibros.27961354083324786425145408321588598
2022;21(6):1061-1065.53914540833468101135148183214229262281292322354389420438469501536570582
6.42515530853652
Ishimaru492155408315417994151184205243
D,75115540834556
Boudko82215540833574112151181218
D,105615540834556
Meleshkevitch112715540835590105140167205235269301317340370408
EA,15501554083337690
et165515540833456
al.17271554083314760
Functional180215540833269107139163178216255287302
Rescue21201554083357097129167202
of233715540833757
CFTR240915540834072107144
by256915540833870
Aerosolized2654155408341759613316019821422942516540832862102
Delivery5421654083468197112144179200234
of79116540833857
Optimized86416540834786108124181197226260299
CFTR117916540834072108145
mRNA133916540835793139180
Using15351654083447084122161
ReCode‑LNPs171216540833570112149188223246279325360387
in211416540831553
Primary21821654083355672129162183217
Human241516540834481139172210
Bronchial26401654083365794133165203218250265
Epithelial4251754083337287110148183198213245261
Cells7021754083397389104130
Derived84817540834581102117150184224
from10881754083184077136
Patients12401754083356788104138177198226
with14821754083506688126
Cystic16241754083406895118134166
Fibrosis.18061754083324786108145171186212226
In:20481754083155365
D109.212917540834577108143154
AIRWAY22991754083415692150189220
OF253517540834781
INTEREST:26321754083146094128163197231265274
EPITHELIAL4251854083336882116162195227242283315
AND75618540834186132
SMOOTH90318540833387135183216261
MUSCLE118018540835498130171202235
FUNCTION143118540833276121162198214262308
IN175418540831560
HEALTH183018540834477120151180226
AND207218540834186132
DISEASE.22191854083466194126169203235248
American248318540834199134155170202235273
Thoracic2772185408332721104251954083215486101133
Society;57319540833371104119153176210223
2022:A5488-A5488.81119540833468101136148191227262298333356397433468504539553
7.42520530853645
Piotrowski‑Daspit4852054083355088110131168219246276293315362394421459475497
AS,9982054083417587
Barone11002054083366990127166201
C,131620540834053
Lin13842054083314784
CY,14842054083397785
et158420540833456
al.16552054083324861
In173120540831452
vivo17992054083314779117
correction19312054083316890112146178203218256294
of224020540833857
cystic23122054083316592115130162
fibrosis2489205408317347395132159174200
mediated2704205408357921321471794252154083225595
by53521540833970
PNA62121540833579120
nanoparticles.75721540833769107146185218239264279311327361388402
Sci11742154083336580
Adv.126921540834180112122
2022;8(40):eabo0522.140721540833468101136148183202235271289301336368407446482516549584596
8.42522530853652
Global4912254083446098137170186
strategy6912254083264971104125159199231
for9362254083185678
the10282254083216095
diagnosis,11372254083385385124162200227242268281
management143222540835890128160199234292327365387
and183322540833270109
prevention19562254083396094127161199221236274312
of228222540833857
COPD;235322540834086122167179
2023.254722540833468101136148
Navštíveno:27092254083457710913615917442523540833266104142155
7.59523540833440
5.65123540833446
2023.71223540833468101136148
Dostupné87623540834584110134172211249284
z:117523540832943
https://goldcopd.org/2023-gold‑report-2/123323540833759831231491621892092452832993383704074474864995375595976236586927257607828228608769159389609941033107210931118113811691195
9.42524530853649
Frazier4932454083325285115130165186
WD,697245408358104115
DaVanzo83024540834578112143181210248
JE,10962454083245770
Dobson118424540834684124151189227
A,142924540834156
et150324540833456
al.15772454083324760
Early16552454083336687103134
Initiation1808245408314526790105137159174212251
of207724540833756
non‑invasive215124540833876115137153191222255282297329363
ventilation253324540833165104125140156188210225263301
at285224540833254
home42525540833876134169
improves60925540831472111133170202236263
survival8862554083266485120135168201216
and111725540833169108
reduces12402554083215594132164198224
healthcare147925540833772104120142180212245266300
costs17942554083316895118145
in195425540831552
COPD202125540834085121166
patients22022554083387193108143181203230
with24472554083506688127
chronic25882554083316990128166181213
hypercapnic2815255408338694252654083397495126159198237252284
respiratory7232654083205481120136157190212249270304
failure:1041265408318526782119141175187
A1242265408341
retrospective1297265408320547798135162201236269293309341375
cohort168626540833168107145167191
study.18912654083264987126158168
Respir20732654083357097136152173
Med.225926540835590129143
2022;241526540833469101136149
200:106920.257726540833469105118148179215249282316328
10.4252753085367085
Brat5232755083355790111
K,64827550833549
Koblížek71027550833573112128143172206237
V.96027550833545
Stanovení10182755083325486124163195229267282
prognózy13132755083396098137175214242276
pacienty160227550833972104119154192213247
s1862275508326
CHOPN190127550834085133169213
–2127275508335
význam21762755083316596135167225
pro24142755083396098
klinickou2525275508329466199114146176213251
praxi2790275508338609342528550833046
a486285508332
jak5332855083154777
na62628550833769
to.7112855083215871
Stud7972855083335492131
Pneumol94328550833573108145203242257
Phthiseol.12162855083357294132147173208247263276
2022;82(2):56-64.150728550833468101136148184217234268286298334368391429465478
11.4252953085366577
McDonald51529540835486131169207239254292
VM,81929540833690103
Gibson9352954083435897123161198
PG.11462954083357892
Treatable12512954083324982114135167206221256
traits1519295408322437590112139
in167129540831452
asthma:17352954083325880118175207219
moving196629540835795126142179217
beyond219629540833873104141179218
diagnostic24262954083385384123160198224247262293
labels.27322954083154685120135161174
Med42530540835490129
J569305408325
Aust.60930540834178104127141
2022;216(7):331-333.76530540833468101136148183215246265299319331366399430449481514547559
12.4253153085366884
Brusselle5293154083355795122148183199214249
GG,79831540834489102
Koppelman92131540833572112152187203261293331
GH.127331540834388102
Biologic13953154083365189105143183198230
Therapies164531540833372108129162201217252278
for19443154083185678
Severe204231540833368100134156190
Asthma.22523154083416993131189221234
N2507315408345
Engl257231540833371110125
J2718315408324
Med.276231540835590130143
2022;386(2):157-171.42532540833468101136148183218253272306324336365396429447478508540549
13.4253353085366883
Jendzjowsky5243354083245997136166181219271297327361
N,90133540834457
Laing9733354083326580118157
A,114533540834156
Malig121633540835487102117156
M,138733540835568
et147033540833457
al.15423354083324760
Long‑term161733540833269107146169191225246305
modulation193733540835795135173188220242257295334
of228633540833756
airway23583354083314768121154185
remodelling255833540832155113151190225241256271309348
in42534540831553
severe4933454083266193127149183
asthma6913454083325882120178210
following916345408319567287125176192230269
bronchial12003454083396098136168206221253269
thermoplasty.14843454083226095116175213252268301327350384394
Eur18933454083336991
Respir19993454083357097136152173
J.218734540832437
2021;59(1):2100622.223934540833468101133141176208227259273285321352383420455489523536
14.4253553085366984
Tyson5273554083336087126164
L,70935540833145
Hardeman7713554083457798136171229261299
W,108835540835767
Marquette117335540835487108146184219241265299
M,149035540835468
et157535540833457
al.16493554083324760
A1727355408341
systematic17863554083265885109142200233254270302
review21053554083215587103138189
of231235540833756
the23863554083216095
characteristics249835540833270102123156188212246267283309332347379407
of42536540833757
interventions5013654083145274107129163198236257273311349375
that8953654083226093114
promote10283654083396198156194216250
physical129736540833977108135150182215230
activity15463654083326488103136152174208
in177336540831553
adults184536540833170108123146173
with20383654083506688126
asthma.21833654083325982120178210223
J2426365408324
Health246936540834479111126149187
Psychol.26753654083356194125163201217230
2022;27(12):2777-2796.42537540833468101136148183216233264294312324359392427461480511544577612626
15.4253853085377288
Wijsenbeek5443854083597794122159199241279316349
M,92438540835671
Suzuki102638540833473105145178196
A,125338540834258
Maher134238540835691131168191
TM.156438540833492108
Interstitial17033854083155579114138167192209233250284301
lung20353854083165596137
diseases.22033854083395684122156184221250265
Lancet.249938540833368109143179203218
2022;274838540833572107144158
400(10354):769-786.42539540833470106126157189222255290308320353385419442474507542556
16.4254053085366985
Raghu52840540833568107145183
G,72840540834458
Remy‑Jardin80340540833671129159181203235256294309347
M,116840540835468
Richeldi12534054083365183121156172211226
L,149740540833145
et155940540833457
al.16334054083324760
Idiopathic17114054083155469107147180201239255287
Pulmonary20154054083357388146184222255276310
Fibrosis23424054083334887108146172187213
(an25734054083194987
Update)267840540834483122154176210227
and42541540833270109
Progressive5484154083365694133154188215242257289323
Pulmonary8864154083357288145184222254276310
Fibrosis12104154083334787108145172187213
in143841540831452
Adults:150541540834179117132154182195
An171441540834179
Official18084154083476784102134149181197
ATS/ERS/JRS/ALAT202041540834069103128162197231256277313347372409441484513
Clinical25484154083405570108123155188203
Practice276641540833556891214254254083223769103
Guideline.5434254083448297136171186201239274286
Am84542540834098
J959425408324
Respir9984254083367197136152173
Crit1186425408340617799
Care13014254083407294128
Med.144442540835490129142
2022;205(9):e18-e47.160242540833468101135148183217251269301319331365395426449485522554560
17.4254353085366876
Raghu51643540833568107145183
G,71443540834357
Remy‑Jardin78643540833570128159181202234255293309346
M,114743540835568
Ryerson123043540833568103124151189228
CJ,14734354083406678
et156643540833457
al.16374354083324861
Diagnosis17124354083466193132170209235250276
of200343540833757
Hypersensitivity207543540834476115151172200235273299314336352384400422456
Pneumonitis254643540833573108145203241280295317333359
in42544540831553
Adults.49244540834179117132155182196
An70244540834180
Official7964454083476785103135150182197
ATS/JRS/ALAT100844540834170103128149185219244281313356385
Clinical14084454083405570108123155188203
Practice16264454083355588121145160192226
Guideline.18664454083448297136171187202239274287
Am216744540834199
J2281445408324
Respir23194454083367198136152173
Crit2507445408340617699
Care26204454083407394128
Med.276344540835489129142
2020;42545540833468101135148
202(3):e36-e69.58845540833569102119153170182216250285308345380414425
Erratum10294554083325375108130168225
in:12704554083145264
Am135045540834199
J1464455408324
Respir15044554083357097136151172
Crit1692455408340617699
Care18064554083407394128
Med.194945540835590129142
2022;206(4):518.210745540833468101136148183217253272305322334369400431445
18.3047553085366985
Baughman31465540833568106145183241273311
RP,3471554083357276
Valeyre3561554083366782117148170205
D,37795540834657
Korsten3849554083357394122145179217
P,40805540833539
et41335540833456
al.4203554083324760
ERS42775540833368102
clinical439355408331466199114146179194
practice4601554083396193126150165197231
guidelines4846554083387590129164180195233268294
on51545540833876
treatment5244554083224377109131189224262283
of30476540833757
sarcoidosis.3119654083265980111148164203241267282308322
Eur3456654083336991
Respir3562654083357097136152173
J.37506540832437
2021;58(6):2004079.38026540833468101133141176210229262280292327362398434470503536547
19.3047753085366982
Brat3148754083355790111
K.32787540833550
Nové33467540834583115149
diagnostické3514754083385385124162200227250265297327361
a389475408332
léčebné3944754083154982116155193228
postupy41917540833877104127165204235
u444575408337
maligního45007540835790105120159197212251290
pleurálního4808754083395489127148181197234249289327
výpotku.51537540833266106145167197235248
Onkologie.542075408347853047854083306783121161176210223
2023;17(1):16-21.32858540833468101136147177207223255269281311342366397428437
20.3047953085367390
Lu31569540833170
P,32459540833541
Sun33059540833271110
Y,34349540833645
Liang3498954083324882121162
B,36799540833549
Yu37479540833572
L.38389540833146
Derivation39039540834682105122156190213230269309
and42319540833271112
validation436295408332668399139173196213252292
of46739540833758
a475095408332
1848019540833466
F‑FDG4882954083335591137184
PET/CT50859540833569105128169206
scoring5310954083266098121138177218
model304710540835797138174191
to325610540832160
predict33331054083396297138155188214
malignant356410540835791108124164204237277300
pleural38811054083395692131154188205
effusion.41041054083345477117145161201240255
Nucl437610540834584118135
Med452810540835491132
Commun.467710540834078138197236276290
2022;43(2):177-185.498510540833469104140154190224243278298311342373409429461494529542
21.30471153085367185
Sundaralingam315511540833271111151185207242259275314355388448
A,362511540834157
Bedawi370511540833572113146198215
EO,39431154083338294
Harriss406011540834478101124141168196
EK,42791154083336985
et438711540833458
al.44681154083314862
The455311540833374110
Frequency,46861154083325389130169205244278313324
Risk50331154083355280111
Factors,51671154083326397122160183212227
and541611540833272112
Management304712540835488127160200236295331370392
of345512540833757
Complications352812540833977136176193209242276299316355394421
From39651254083325391150
Pleural41301254083355187126148182198
Procedures.43441254083355795129163204242264300327342
Chest.470212540833978114142166181
2022;161(5):1407-1425.489812540833469103139152183215247263297317330361393430463483515547581616630
22.30471353085367491
Luengo‑Fernandez315413540833170106146186226250286321344384418457497534565
R,373413540833651
Landeiro380113540833166106146182199221260
F,407713540833240
Hallifax41321354083447895112128149183216
R,436413540833551
et443113540833457
al.45041354083324963
Cost‑effectiveness458313540834078106131152190210233269303329346379415455491519547
of514613540833758
ambulatory522013540833291131171188221245283304714540832156
care31211454083316588123
management326214540835791130164204241300336376399
of367814540833758
primary37541454083386178137171194229
spontaneous400114540832666106146169203243279319359386
pneumothorax:440514540833978115154213253276316356379413446461
an488414540833171
open‑label,497214540833778115155179197230271308325339
randomised53281454083215595135175304715540835774101138179
controlled324415540833169109132155194211227264305
trial.3567155408321446195111126
Thorax.371115540833273113136170203218
2022;77(9):913-918.394715540833570104141154189224242276296309345379410433470503536550
23.30471653085367490
Herbst315516540834481103144172197
RS,33691654083367185
Wu347216540835795
YL,35851654083356984
John368616540832564104144
T,384716540833343
et390716540833458
al.39831654083314862
Adjuvant40631654083418197136170205244267
Osimertinib43481654083467591150187209235252291308348
for47141654083185780
Resected481216540833571100136170196231272
EGFR‑Mutated510116540833378113149173230269293327351386427
Stage30471754083325589130166
IB‑IIIA3229175408315527795111128170
Non‑Small‑Cell341617540834584124148181240274290307331375410427443
Lung387617540833170109150
Cancer:404217540834074114147182205220
Updated427917540834484125159182217258
Results455317540833672100139156179208
From47781754083325392152
the49461754083226298
Phase506117540833573107135171
III52491754083153148
Randomized531417540833569109149189304718540835774104140181
ADAURA324618540834188129173210255
Trial.35191854083325168101118132
J3670185408324
Clin37121854083405673112
Oncol.384218540834787121159176191
2023;41(10):1830-1840.405118540833469104140153189220237270303323336367400435471496528561599636650
24.30471953085367289
Solomon31591954083337290129189229269
BJ,34511954083356175
Bauer354919540833570109145168
TM,374019540833389104
Mok386819540835494126
TSK,401719540833368104120
et416019540833458
al.42411954083324963
Efficacy4328195408332527593126161194229
and458019540833272112
safety47151954083276182118141176
of491519540833758
first‑line4996195408318365887112133151167207243
lorlatinib5262195408315557895129152169208224265
versus30472054083326790119157185
crizotinib32492054083315471101140163180219236276
in354220540831554
patients36142054083387396112148188211240
with38712054083516892131
advanced,401920540833273107141180214249290304
ALK‑positive434020540834174111132174214242258282299333368
non‑small‑cell472620540833777117140169228262278295318354389406422
lung51652054083155493134
cancer:531620540833165105138174196211
updated304721540833778119152176211252
analysis332121540833272105122155184200227
of357121540833858
data36522154083387295129
from38042154083184281140
the39672154083226198
phase408721540833979113141177
3,428721540833447
randomised,43572154083215595135175234251278315356370
open‑label475021540833778115154178196230270307324
CROWN509721540834077126185232
study.53522154083265190131164175
Lancet304722540833166106139174198
Respir326322540833572100140157180
Med.346122540835491132146
2023;11(4):354-366.362622540833469103140152184213230264283296333367404428462498535549
25.30472353085367489
de315223540833874
Langen324223540833166105145181220
AJ,34782354083416982
Johnson357623540832463103142170209249
ML,384023540835588103
Mazieres395823540835588119136172194230258
J,423123540832438
et428423540833458
al.,4357235408332496377
CodeBreaK444923540834078119155192215250283320
200478523540833469106
Investigators.49072354083155486122150174191231264287325348376391
Sotorasib5314235408332729513315619030472454083264282
versus31452454083316789118156183
docetaxel334424540833877111146169203236271288
for36482454083185779
previously37432454083386196130147186225253269302
treated40612454083214479112135170210
non‑small‑cell428724540833777116140168227260277293316351386403419
lung47222454083155392132
cancer487024540833165104138172195
with50802454083516891131
KRASG12C522624540833573117152198229261301
mutation:304725540835796120155178194234274287
a3352255408332
randomised,34022554083215595135175234251278315356370
open‑label,379025540833778115155178196230270307324338
phase414625540833979112140177
34341255408334
trial.4393255408322456295112126
Lancet.453725540833267106140175198213
2023;401(10378):733-746.476825540833470104140153189227260276309342377410445464478512548582606638670708722
26.30472653085367289
Goldman315226540834383100140199232271
JW,34382654083248394
Dvorkin354826540834579118140172190228
M,379226540835468
Chen387626540833978114153
Y,404526540833544
et410426540833458
al.41772654083314862
CASPIAN425426540834084119154170212258
investigators.45282654083145385121148173189229262285323345374388
Durvalumab,493226540834584106142176193231290323363376
with53242654083506790129
or546926540833759
without30472754083506790130169208232
tremelimumab,32942754083214479138174191207265304362396436449
plus37592754083385593121
platinum‑etoposide38952754083395689112128167205264288325348386427467494510550586
versus44962754083326789118156183
platinum‑etoposide46952754083385588111127166205264287324348386426466494510550586
alone52962754083314887126162
in547427540831453
first‑line3047285408318355684107128144160198233
treatment32952854083214377109132189225263285
of359428540833757
extensive‑stage36652854083336590124162189204237272295323346379418454
small‑cell413328540832683116132147170204238254270
lung44172854083155291130
cancer456128540833164102134168190
(CASPIAN):476628540831857100134169184225271290303
updated508328540833676115148170204244
results53412854083215582119135158186
from30472954083184178137
a3198295408332
randomised,32442954083215492132170229244271306346360
controlled,361829540833168107129151189206222257297310
open‑label,394329540833676112151174191223263299315328
phase428629540833877110137172
34473295408334
trial.4521295408321446092108122
Lancet465829540833165103136170193
Oncol.486529540834685118155172186
2021;22(1):51-65.506529540833468102134143178213231263279291327358378415449462
27.30473053085367383
Baas315330540833570104132
P,330830540833541
Scherpereel337330540833266106142165206244266302339356
A,375230540834157
Nowak383230540834585138172204
AK,40593054083417894
et417730540833458
al.42583054083324963
First‑line43443054083334972101125146164180220256
nivolumab46243054083375488127145184243277318
plus49653054083395695123
ipilimumab5112305408314557289105164204263297338
in547330540831554
unresectable30473154083377799135163199233259293334351387
malignant345631540835791108124164204237277300
pleural37773154083395692131154188205
mesothelioma400431540835794122161185224261278294333393427
(CheckMate44523154083196099135169201259293316351
743):482531540833466100118132
a4978315408332
multicentre,503131540835897113137154187222262285308343356
randomised,54093154083215594304732540833878137154181218259273
open‑label,333832540833778115155178196230270307324338
phase369432540833979112140177
33889325408334
trial.3941325408322456295112126
Lancet.408532540833267106140175198213
2021;397(10272):375-386.431632540833470104137147183218252270303336370404440459473509543577600634670707721
28.30473353085367391
World315533540835795118135176
Health334833540834480114131154194
Organization.355933540834770110143183199230265288305344384398
Rapid397533540833569110127167
communication:415933540833169129188227267283317351374391430470484
key46603354083296598
changes477533540833170104144184220249
to504133540832160
the51183354083216197
treatment52333354083214480113136195232271294
of304734540833758
drug‑resistant312134540833860100140164187223251267295319354393416
tuberculosis.355334540832161101138161193232249289317333361375
Cited:39443454083405781116157170
6.413034540833449
5.419534540833447
2023.425834540833470104140154
Available442834540834173107124140174214232268
from:47123454083184280140154
https://www.who.int/48813454083386186127155169198219272327381393444484524538555594617646
publications/i/item/WHO‑UCN‑TB-2022-230473554083397811913615218622024326029933936739441243945648051557560266471176078583287492194597610141039107111061141117711991231
29.30473653085367388
Günther315536540834483123146185222244
G,341836540834459
Ruswa349636540833574102155190
N,370536540834459
Keller37833654083357087104140163
PM.396536540833590105
Drug‑resistant408936540834669109149173196232260276304328362402425
tuberculosis:453336540832161101138161193232249289317333361374
advances492736540833172106140180213248277
in522336540831454
diagnosis5296365408338548812816820730473754083264270
and313537540833271112
management.326537540835791130164204241300336376399414
Curr369737540834078100123
Opin383837540834789106145
Pulm40013754083357490149
Med.416937540835490131146
2022;28(3):211-217.433337540833470104140154190225246281299313349382411431464496527535
30.30473853085367490
Nyang‘wa315338540834578112152192206259293
BT,34623854083357081
Berry35583854083367295118154
C,372738540834055
Kazounis379738540833570101140179219235263
E,407638540833247
et413938540833357
al.;4212385408332496377
TB‑PRACTECAL43053854083327195133170214255292327369413446
Study47673854083335594135168
Collaborators.49513854083407896112146186226249284307345368397412
A5379385408341
24Week,543638540833467304739540835894132164181
All‑Oral32523954083425976101153177213230
Regimen350639540833674116133193231271
for38013954083195983
Rifampin‑Resistant39083954083365475111171213231271295335372401418447472507548571
Tuberculosis.450339540833369111149172206246263304333349378393
N4920395408346
Engl499039540833374115132
J5146395408325
Med.519539540835693135150
2022;536939540833572107144158
387(25):2331-2343.304740540833470104122157194213227263300334366386419455492526540
31.30474153085377388
Conradie316041540834181123146182224242280
F,346541540833341
Bagdasaryan353141540833773115157192221258281318354395
TR,39514154083347490
Borisov406641540833778103121149191226
S,431741540833348
et439141540833459
al.;4476415408332506580
ZeNix458141540833976125142176
Trial47824154083345472106124
Team.493141540833468102164179
Bedaquiline­513641540833674117152194235252270287328366392
‑Pretomanid‑Linezolid30474254083216184121146186247282323340382407443460501539571611629647688
Regimens376042540833674116134195233274302
for40874254083195983
Drug‑Resistant419542540834670112153178218256285302331357392433457
Tuberculosis.467642540833470112150174208248266307336353382398
N5098425408346
Engl516942540833374116133
J5327425408324
Med.537642540835694136151
2022;387(9):810-823.304743540833470104140154190226260278312332345381414447472510545581595
32.30474453085367289
Suska31534454083327199130165
K,333444540833551
Amati3402445408340100134157173
F,359244540833239
Sotgiu36484454083327295134151190
G,385444540834458
et392944540833457
al.40034454083314863
Nontuberculous408244540834484124147186227264286319358375414454482
mycobacteria458044540835789122160201236269295330353370403
infection49994454083155474110144170187226266
and528144540833271112
pulmonary54094454083397895304745540835797137171193229
disease32944554083385482118152179216
in352845540831554
bronchiectasis.360045540833962100140174213230266300325359387404431446
ERJ40644554083337098
Open418045540834788125165
Res.436345540833572100115
2022;8(4):00060-2022.449645540833470104140154190211245264277314352389426463489521556591627641
„592640208960
HLAVNÍ7326343016688149233296385413
TÉMA:11766343016665130237318342
Alergologie15496343016682110176216288362390464540567633
a22126343016664
imunologie23076343016629141213286359388461537564631
„592660008960
Multimorbidita73265410166109181209250278390464504580608682709751813
při15766541016677117145
akutním17526541016663120194236309336448
poškození22316541016677152202259330383448521548
a28106541016663
selhání29046541016652119147219281353380
ledvin3315654101663096172234263335
„592679808960
Endoskopická7326739016665138213286336392464540568629686750
a15126739016664
chirurgická16076739016662135162201274313386413474531595
léčba2233673901662996158233296
obezity25596739016675151219275303345409
„592699708960
Vnútrohrudná7326938016671142214256296367441480554628701763
infekcia15256938016630102136202260319346407
vyvolaná19626938016663129196268297358431492
baktériou24856938016677140197243307347375448521
Delftia30366938016691159187222269297357
acidovorans34246938016664125152226300360432472535608657
–41126938016670
kazuistika7327108016659123179253280329372399456520
„592736508960
Subklinická7327306016665136211270300326399426487544608
hypotyreóza13707306016675133210285325390431495570623687
ve20877306016664129
zkratce22477306016656114156219259317381
„592756308960
Diferenciální7327504016691119154220259324397458485546573646672
diagnostika14357504016676103164239312385435479506563627
kožních20937504016659130184258285345418
krvácivých25417504016660101168231292319381447507579
projevů31517504016677117189216283344417
▼496662710233168
vyjde48806579018874154189269339
v48386779018874
říjnu49506779018871103136225311
2023481350710313105241349455
Připravujeme58751300450206335425616746921110112911379155418422017
do267551300450174350
Vnitřního58755700450217399487618747937102412201409
lékařsví2067557004508726244662475490810931181